Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275145 · ClinicalTrials.gov registry record · Phase 2
Effects of Resistance and Aerobic Exercise on Cardiovascular Health
A Phase 2 study of Obesity and Cardiovascular Diseases, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 261
- Enrollment target
- 1
- Study location
NCT00275145 is a Phase 2 study of Obesity and Cardiovascular Diseases that has completed, run by Duke University. The registered enrollment target is 261 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00275145, a Phase 2 study of Obesity and Cardiovascular Diseases, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 261 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the separate and combined effects of aerobic and resistance training on cardiovascular risk factors in overweight men and women with mild to moderate dyslipidemia.
Conditions Studied
Interventions
- BEHAVIORAL Resistance Training
- BEHAVIORAL Aerobic Exercise
- BEHAVIORAL Combo
- BEHAVIORAL Continued Sedentary lifestyle
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 261 participants |
| Start Date | 2004-05 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00275145
The ClinicalTrials.gov registry entry for NCT00275145 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 261 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Obesity appearing as the primary indexed condition, and to 4 interventions - of which Resistance Training is the first listed.
NCT00275145 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00275145 about?
NCT00275145 is a clinical study titled "Effects of Resistance and Aerobic Exercise on Cardiovascular Health". This study will investigate the separate and combined effects of aerobic and resistance training on cardiovascular risk factors in overweight men and women with mild to moderate dyslipidemia.
What is the current status of trial NCT00275145?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 261 participants. The study started on 2004-05. Estimated completion is 2008-12.
What conditions does trial NCT00275145 study?
This clinical trial studies the following conditions: Obesity, Cardiovascular Diseases, Insulin Resistance, Heart Diseases, Hyperlipidemia.
What interventions are being tested in trial NCT00275145?
The interventions under investigation include: Resistance Training (BEHAVIORAL), Aerobic Exercise (BEHAVIORAL), Combo (BEHAVIORAL), Continued Sedentary lifestyle (BEHAVIORAL).
Who is sponsoring clinical trial NCT00275145?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00275145 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatment After Bariatric Surgery
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.